行业
显示 6061-6070 个结果(共 6251 个结果)
-
Agar-Agar Market in China 2021
从收入来看, the agar-agar market in China is projected to grow at a compound annual growth rate (复合年增长率) 的 7.9% 在分析期间 2021 到 2027, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the agar-agar market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Carrageenan Market in China 2021
The carrageenan market in China in terms of revenue is set to grow by US$ 335 期间百万 2021-2027, 以复合年增长率增长 (复合年增长率) 的 11.4% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the carrageenan market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Biologics Market in China 2021
The biologics market in China in terms of revenue is set to grow by US$ 109 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 19.3% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the biologics market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Temozolomide Capsules Market in China 2021
从收入来看, the temozolomide capsules market in China is projected to register a negative compound annual growth rate (复合年增长率) 的 -0.7% 在分析期间 2021 到 2027, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the temozolomide capsules market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Coronary Intervention Device Market in China 2021
The coronary intervention device market in China in terms of revenue is set to grow by US$ 1 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 9.2% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the coronary intervention device market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
PCI (Percutaneous Coronary Intervention) Supporting Device Market in China 2021
The PCI (percutaneous coronary intervention) supporting device market in China in terms of revenue is set to grow by US$ 468 期间百万 2021-2027, 以复合年增长率增长 (复合年增长率) 的 9.4% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the PCI (percutaneous coronary intervention) supporting device market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Medical Device (Ex-Factory Price Level) 中国市场 2021
The medical device (ex-factory price level) 中国市场的收入预计将增长 美元 126 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 12.2% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the medical device (ex-factory price level) 市场帮助行业高管做出明智的决策, 政策制定者, 学术的, 和分析师.
-
Outdoor Advertising Market in China 2021
The outdoor advertising market in China in terms of revenue is set to grow by US$ 5 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 3.8% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the outdoor advertising market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
TV Advertising Media Services Market in China 2021
The TV advertising media services market in China in terms of revenue is set to grow by US$ 6 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 3.7% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the TV advertising media services market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
-
Advertising Market in China 2021
The advertising market in China in terms of revenue is set to grow by US$ 67 亿期间 2021-2027, 以复合年增长率增长 (复合年增长率) 的 7.1% 在预测期内, 据数据和分析公司 StrategyHelix 称. 该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the advertising market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.